903 Human cancer-associated fibroblast subsets can predict immune checkpoint response in head and neck cancer patients

• Yu Wang,
• Andrea Califano,
• Young Kim,
• Michael Gibson,
• Charles Drake,
• Yaomin Xu,
• Ravindra Uppaluri,
• Adam Luginbuhl,
• Aleksandar Obradovic,
• Joseph Curry,
• Michael Korrer,
• Diana Graves,
• Sohini Roy,
• Paula Hurley

Affiliations

Yu Wang

1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

Andrea Califano

Columbia University, New York, NY, USA

Young Kim

Department of Surgery, University of Cincinnati Medical Center, Cincinnati, Ohio, USA

Michael Gibson

Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA

Charles Drake

1Columbia University Irving Medical Center, New York, NY, USA

Yaomin Xu

Aff1 0000 0004 1936 9916grid.412807.8Department of BiostatisticsVanderbilt University Medical Center 37232 Nashville TN USA

Ravindra Uppaluri

Aff13 0000 0004 0378 8294grid.62560.37Brigham and Women’s Hospital and Dana-Farber Cancer Institute Boston MA USA

Adam Luginbuhl

Aff1 0000 0001 2166 5843grid.265008.9Department of Otolaryngology—Head and Neck SurgeryThomas Jefferson University 925 Chestnut Street, 6th Floor 19107 Philadelphia PA USA

Aleksandar Obradovic

Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York, USA

Joseph Curry

Department of Paediatric Surgery, Great Ormond Street Hospital NHS Trust, London, UK

Michael Korrer

Vanderbilt University, Nashville, TN, USA

Diana Graves

1Vanderbilt University, Antioch, TN, United States

Sohini Roy

3Vanderbilt University Medical Center, Nashville, TN, United States

Paula Hurley

3Vanderbilt University Medical Center, Nashville, TN, United States